Skip to main content
ON Helix is One Nucleus’ flagship summer translational research confernece. The 2018 conference was the sixth in this series, with the strapline ‘Translating UK scientific excellence into global scientific strategies’; a different format, over two days rather than one; and a new venue, the Cambridge building at Babraham Research Campus. This landscaped site, six miles south-east of Cambridge city centre, is home to about sixty organisations including many established and startup biotech companies. Delegates clearly valued the extended format, with both days fully subscribed, and the…
A year ago I was pleased to be given the opportunity to assume the role of CEO at One Nucleus. The Board and I agreed there were some key developments that we wanted to implement in order to enhance the effectiveness and relevance of One Nucleus to our members, the region and the sector as a whole.   A nod to the past…. Perhaps counter-intuitively as we considered our forward looking strategy, it was looking back that enabled us to ascertain where One Nucleus’ future direction should be. Reminding ourselves of the origin and role of regional cluster groups such as Eastern Region…
The UK is at the forefront of life sciences innovation. Break through companies across the UK are creating cutting edge therapies, highly skilled jobs, and driving economic growth. But business and Government recognise that more still needs to be done to create stronger links between the life sciences and business community. Large pharmaceutical companies, the likes of GlaxoSmithKline or AstraZeneca, may dominate the headlines and the attention of investors but the ground breaking work is often being done by growing and specialist firms. It is these companies that need our support if we are…
Recently, I was fortunate to be invited to the Kruger Cowne Breakfast Club event held in London to hear two of their clients – Caroline Rush (CEO, British Fashion Council) and Millie Mackintosh (Entrepreneur, Designer, Model and Fitness & Health Ambassador) – discuss aspects of the fashion industry, supporting creative talent, entrepreneurship and business from their perspective. See some selected highlights at http://www.krugercowne.com/events/caroline-rush-millie-mackintosh/ Fashion may feel a long way from Life Sciences & Healthcare, but it was striking how so many of the…
The Prism Series “pop up event” Cancer research UK December 2017 Christmas comes but once a year. To most of us this is a really good thing as it costs so much. We look forward to all the festivities, parties and of course the consumption of too much food and drink. Part of the annual festivities is the annual Genesis Life Sciences conference held in London, pretty much on the same date every year. The conference which is the brainchild of Tony Jones and his team brings together all of the UK life science community to participate in discussions, exchange business cards and sometimes do…
This is a guest post for One Nucleus by Toby Beresford. Toby is the Founder and CEO of success tracking network Rise.global. Previously he has worked as a developer of web based disease management for patients, dermatology tele-referrals for GPs and was deputy chairman of the public health sub-committee for Wandsworth Council. His email address is toby@rise.global At the recent PRISM Series Dave Snowden told the story of how he self-managed his recovery from Type 2 diabetes – he called it his hero’s journey. It’s a story he has told before in a blog post “Early Detection, Fast Recovery”.…
Putting the c in Science – Commercialization, Community and CapitalI am very much looking forward to my up and coming talk at the 2017 ON Helix conference. As an early stage investor, I especially enjoy opportunities to talk with and learn from life science innovators. You see, for me, science is quite personal. My talk at the conference will focus on the three c’s of science: Commercialization, Community and Capital. This blog will give you a sample of what I look forward to discussing with the conference attendees. For me, these speaking opportunities keep me connected to innovation and…